Research and Markets has announced the addition of the "Post-Operative Pain Pipeline Highlights - 2017" drug pipelines to their offering.

Post-Operative Pain Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Post-Operative Pain market. It covers emerging therapies for Post-Operative Pain in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Post-Operative Pain pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Post-Operative Pain pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Post-Operative Pain pipeline products by the company.

Short-term Launch Highlights:

Find out which Post-Operative Pain pipeline products will be launched in the US and Ex-US till 2020.

Key Topics Covered:

1. Post-Operative Pain Pipeline by Stages

2. Post-Operative Pain Pipeline by Drug Class

3. Post-Operative Pain Pipeline by Company

4. Post-Operative Pain Phase 3 Clinical Trial Insights

5. Post-Operative Pain Phase 2 Clinical Trial Insights

6. Post-Operative Pain Phase 1 Clinical Trial Insights

7. Post-Operative Pain Preclinical Research Insights

8. Post-Operative Pain Discovery Stage Insights

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/rbpfwt/postoperative